Browsing by Author "Trabulo, C."
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- Is preoperative chemosensitivity associated with improved outcomes in locally advanced gastric cancer? A multicentric retrospective real-world studyPublication . Caleça, T.; Honório, M.; Sousa, M.; Ribeiro, J.; Fortuna, A.; Silva, D. Neto da; Albuquerque, J.; Menezes, M.; Trabulo, C.; Costa, D.Perioperative chemotherapy (PCT) is the standard of care for locally advanced gastric cancer (LAGC) in western countries. However, less than 60% of patients complete the adjuvant part of treatment due to postoperative complications, toxicity and disease progression (DP). This study aim is to evaluate if preoperative chemosensitivity (POCS) is associated with improved overall survival (OS) and disease free survival (DFS).
- Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are not predictive of pathologic complete response to neoadjuvant chemotherapy in triple-negative breast cancerPublication . Pinho, I. Soares de; Barroso, T.; Trabulo, C.; Campoa, E.; Patel, V.; Gonçalves, L.; Araújo, J.; Monteiro, C.; Ferreira, A.; Machado, B.; Dâmaso, S.; Luz, P.; Sousa, R. Teixeira de; Costa, L.Pathological complete response (pCR) to neoadjuvant chemotherapy (NAChT) has been validated as a predictor of long-term survival in breast cancer (BC), especially in triple-negative breast cancer (TNBC)